HALO — HALOZYME THERAPEUTICS INC

Ownership history in M&G Plc  ·  2 quarters on record

This page tracks every 13F SEC filing in which M&G Plc reported a position in HALOZYME THERAPEUTICS INC (HALO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q3)
Avg. % of fund
0.05%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 160,435 +7,369 +4.8% 0.06% $11.7M $73.34
2024 Q3 INITIATED 153,066 — — 0.03% $8.7M $57.24
% of Fund (quarterly)    HALO price (monthly, adj. close)

Other funds also holding HALO

As of 2025 Q4 — sorted by position size

Koa Wealth Management, LLC 4.3% SNYDER CAPITAL MANAGEMENT L P 3Y 7Y 3.01% Steamboat Capital Partners, LLC 3Y 7Y 2.66% South Street Advisors LLC 3Y 7Y 2.19% BERNZOTT CAPITAL ADVISORS 3Y 7Y 2.17% 2Xideas AG 3Y 1.98% Future Fund LLC 3Y 1.77% MIZUHO MARKETS AMERICAS LLC 3Y 1.65% Verity Asset Management, Inc. 3Y 7Y 1.53% RENAISSANCE GROUP LLC 3Y 7Y 1.3%
← Back to M&G Plc Holdings